Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840050 | 0.82 | TDP1 (0.37) | TDP1SMN1; SMN2 | |
| SCHEMBL840051 | 0.82 | TDP1 (0.37) | TDP1SMN1; SMN2 | |
| SCHEMBL878231 | 0.82 | TDP1 (0.37) | TDP1SMN1; SMN2 | |
| SCHEMBL840049 | 0.82 | TDP1 (0.37) | TDP1SMN1; SMN2 | |
| SCHEMBL838795 | 0.75 | SMN1; SMN2 (0.38) | SMN1; SMN2 | |
| SCHEMBL838796 | 0.75 | SMN1; SMN2 (0.38) | SMN1; SMN2 | |
| SCHEMBL840194 | 0.75 | SMN1; SMN2 (0.38) | SMN1; SMN2 | |
| SCHEMBL839450 | 0.75 | — | — | |
| SCHEMBL839647 | 0.75 | — | — | |
| SCHEMBL839451 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2324028-A2 | THERAPEUTIC AGENTS 414 | AstraZeneca AB (SE) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010015849-A2 | THERAPEUTIC AGENTS 414 | ASTRAZENECA AB (SE) | 2010-02-11 | — | — | WO | disclosed |